UK biotech using AI and aging clocks to discover single-gene factors that safely rejuvenate cells, led by its SB000 target.
Epigenetic reprogramming biotech using transcription factors to restore youthful gene expression in aging cells, starting with the liver.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →